Paulzen, Michael
Stingl, Julia C.
Augustin, Marc
Saßmannshausen, Helena
Franz, Cordula
Gründer, Gerhard
Schoretsanitis, Georgios http://orcid.org/0000-0002-3851-4117
Article History
First Online: 25 September 2018
Compliance with Ethical Standards
:
: Drs. Saßmannshausen, Franz, Schoretsanitis, Stingl, Augustin, Gründer, and Paulzen participated in the research design of the study. Drs. Schoretsanitis and Paulzen performed the initial statistical analyses. Dr. Schoretsanitis and Dr. Paulzen wrote the first article draft. All authors contributed to the interpretation of data and approved the final manuscript.
: No commercial organizations had any role in the completion or publication of this study. Dr. Schoretsanitis received a grant from the bequest “in memory of Maria Zaoussi”, State Scholarships Foundation, Greece, for clinical research in psychiatry for the academic year 2015–2016.
: Gerhard Gründer has served as a consultant for Allergan (Dublin, Ireland), Boehringer Ingelheim (Ingelheim, Germany), Eli Lilly (Indianapolis, IN, USA), Janssen-Cilag (Neuss, Germany), Lundbeck (Copenhagen, Denmark), Ono Pharmaceuticals (Osaka, Japan), Otsuka (Chiyoda, Japan), Recordati (Milan, Italy), Roche (Basel, Switzerland), Servier (Paris, France), and Takeda (Osaka, Japan). He has served on the speakers’ bureau of Eli Lilly, Janssen Cilag, Neuraxpharm (Langenfeld, Germany), Lundbeck, Otsuka, Recordati, Roche, Servier, and Trommsdorf (Aachen, Germany). He has received grant support from Boehringer Ingelheim and Roche. He is co-founder of Mind and Brain Institute GmbH (Zornheim, Germany) and Brainfoods GmbH (Zornheim, Germany). He reports no conflict of interest with this publication. Michael Paulzen, Julia C. Stingl, Marc Augustin, Helena Saßmannshausen, Cordula Franz, and Georgios Schoretsanitis had no conflicts of interest during the last 12 months.